Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Total Liabilities: 2018-2024

Historic Total Liabilities for Whitehawk Therapeutics (WHWK) over the last 7 years, with Dec 2024 value amounting to $17.8 million.

  • Whitehawk Therapeutics' Total Liabilities fell 41.48% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year decrease of 41.48%. This contributed to the annual value of $17.8 million for FY2024, which is 34.48% down from last year.
  • According to the latest figures from FY2024, Whitehawk Therapeutics' Total Liabilities is $17.8 million, which was down 34.48% from $27.2 million recorded in FY2023.
  • Whitehawk Therapeutics' 5-year Total Liabilities high stood at $31.3 million for FY2020, and its period low was $17.8 million during FY2024.
  • For the 3-year period, Whitehawk Therapeutics' Total Liabilities averaged around $23.6 million, with its median value being $25.9 million (2022).
  • Per our database at Business Quant, Whitehawk Therapeutics' Total Liabilities spiked by 818.93% in 2020 and then tumbled by 34.48% in 2024.
  • Whitehawk Therapeutics' Total Liabilities (Yearly) stood at $31.3 million in 2020, then crashed by 31.20% to $21.5 million in 2021, then grew by 20.25% to $25.9 million in 2022, then climbed by 5.29% to $27.2 million in 2023, then slumped by 34.48% to $17.8 million in 2024.